Regarding the influence of food intake on the oral absorption of a drug:

Erlotinib is an orally administered anticancer agent that undergoes elimination via both renal and hepatic pathways. The drug exhibits an oral bioavailability of approximately 60%. Following oral administration, if 20% of the administered dose is recovered unchanged in feces, determine the hepatic extraction ratio (ER) for this drug. Assume that the liver is the sole site of metabolic clearance and that biliary excretion of the unchanged drug is negligible.

Drugs with which characteristics tend to accumulate more when administered repeatedly?

Drug A and Drug B both interact with the same receptor. Drug A exhibits an Emax of 15%, an EC50 of 5 nM, and a Hill coefficient of 2.1. Drug B demonstrates an Emax of 95%, an EC50 of 20 nM, and a Hill coefficient of 0.5. Which of the following statements is correct?

Drugs with which characteristics tend to accumulate more when administered repeatedly?

With respect to flip-flop kinetics, which of the following statements is correct?

Regarding two-compartment pharmacokinetics with first-order elimination, which of the following statements is correct?

In the context of multiple dosing of a given drug, if the dosing interval (τ) is reduced while the bioavailability (F), dose (D), volume of distribution (V), and elimination rate constant (k) remain constant, the fluctuation between the peak and trough concentrations at steady state will:

The intrinsic clearance of a drug with a hepatic extraction ratio (ER) greater than 0.7 may be influenced by changes in:

Ceftriaxone is eliminated exclusively via hepatic and renal pathways and exhibits a total clearance of 42 L/h. Following intravenous administration, 67% of the administered dose is recovered in urine as unchanged drug, while 11% is recovered as metabolites. Based on this information, the biliary clearance of ceftriaxone is: